Maxwell John T. 4
4 · Aquestive Therapeutics, Inc. · Filed Nov 26, 2018
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-11-21$9.80/sh+10,000$98,000→ 148,614 total
Footnotes (1)
- [F1]Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.